Germline mutations in BAP1 predispose to melanocytic tumors

By T. Wiesner, A. Obenauf, R. Murali, I. Fried, K. Griewank, Peter Ulz, C. Windpassinger, W. Wackernagel, Shea Loy, I. Wolf and 14 more. Nature Genetics, 2011

692 citations recorded by the source corpus.

Common acquired melanocytic nevi are benign neoplasms that are composed of small, uniform melanocytes and are typically present as flat or slightly elevated pigmented lesions on the skin. We describe two families with a new autosomal dominant syndrome characterized by multiple, skin-colored, elevated melanocytic tumors. In contrast to common acquired nevi, the melanocytic neoplasms in affected family members ranged histopathologically from epithelioid nevi to atypical melanocytic proliferations that showed overlapping features with melanoma. Some affected individuals developed uveal or cutaneous melanomas. Segregating with this phenotype, we found inactivating germline mutations of BAP1, which encodes a ubiquitin carboxy-terminal hydrolase. The majority of melanocytic neoplasms lost the remaining wild-type allele of BAP1 by various somatic alterations. In addition, we found BAP1 mutations in a subset of sporadic melanocytic neoplasms showing histological similarities to the familial tumors. These findings suggest that loss of BAP1 is associated with a clinically and morphologically distinct type of melanocytic neoplasm.

Subfields: Cancer Research, Oncology, Ophthalmology

View Paper: https://www.semanticscholar.org/paper/e89a1a8e6751f84e200895eeb8dc9d825acdefd1

Citations in the corpus